Biovista President Dr. Aris Persidis will be presenting at the New York Biotechnology Association 2013 Annual meeting. Dr Persidis will be presenting at the “Patient Perspectives: Seeking Cures, Not Just Returns” session and discuss Biovista’s work to date with Patient Advocacy Groups. According to the organizers “patient groups and disease foundations, no longer content to … Read More
Month: May 2013
GEN: Seasoned Drugs Offer Therapeutic Gold Mine
Article by Caitlin Smith GEN: Genetic Engineering & Biotechnology, May 15, 2013 … Biovista has already repositioned two drugs for the progressive form of multiple sclerosis (MS), which has had few treatment options. Most MS drugs, for treatment of the relapsing-remitting form of MS, compromise the patients’ immune systems and have significant side effects. Biovista … Read More